|
Q1 FY2027
As of Aug 31, 2026
|
Q4 FY2026
As of May 31, 2026
|
|
|---|---|---|
| Cash | ||
| Prepaid expenses | ||
| Accounts receivable | ||
| Accounts receivable gross | ||
| Allowance for credit losses | ||
| Research advance, current | ||
| Deferred offering costs | ||
| Total current assets | ||
| Equipment at cost | ||
| Accumulated depreciation | ||
| Equipment net | ||
| Total Non-Current assets | ||
| Software at cost | ||
| Accumulated amortization | ||
| Software net | ||
| Research advance, noncurrent | ||
| Total assets | ||
| Accrued expenses | ||
| Accounts payable | ||
| Short-term loans from shareholder | ||
| Short term borrowings | ||
| Deferred revenue | ||
| Income tax payable | ||
| Total liabilities all current | ||
| Non-Current Liabilities | ||
| Total Liabilities | ||
| Common stock par value 0.02 | ||
| Additional paid in capital | ||
| Accumulated deficit | ||
| Total equity | ||
| Total liabilities and equity |
Loading...
